This new IP supports crofelemer’s global exclusivity in rare pediatric intestinal failure coincident with published clinical data showing reductions in parenteral support requirements with crofelemer ...

Crofelemer can potentially extend lives of MVID patients – infants and children who face the lethal natural history of the disease Parenteral support reduction of up to 37% is groundbreaking; No ...

A generic teduglutide reduced parenteral nutrition requirements in 96% of pediatric patients within 24 weeks in clinical ...

Please provide your email address to receive an email when new articles are posted on . Patients had a mean change in albumin levels of 0.33 g/dL after 6 months of nutrition therapy. In addition, 82% ...

Newborns, weighing <1250 g, received standard (S) or higher (H) parenteral AA intakes (3 or 4 g kg −1 per day). Anthropometry, biochemistry and quantitative ultrasound (metacarpus bone transmission ...

E ris Lifesciences has moved to strengthen its presence in the pharmaceutical manufacturing space with the acquisition of a ...

The role of nutrition in patient care became a part of mainstream medicine at about the end of the 1960s, with the publication of several papers that showed a benefit of nutritional support in the ...

This Journal feature begins with a case vignette that includes a therapeutic recommendation. A discussion of the clinical problem and the mechanism of benefit of this form of therapy follows. Major ...

Compared to other dosage forms, Parenteral Products present unique challenges in both their development and manufacture as their method of administration requires sterile and pyrogen free products.

Oral and parenteral antipsychotics showed similar outcomes in patients with schizophrenia experiencing agitation who presented to the emergency department (ED) with violent behavior, with no ...

According to the DataM market research report, the global large volume parenteral (LVP) market size was valued at US$ billion in 2022, it is projected to reach US$ 13.49 billion by 2030, with growth ...

Visual inspection of parenteral vials is the first step in a root cause investigation. Visual inspection of pharmaceutical containers is an important step to ensure quality control and patient safety.